| Patients with coronavirus disease-19 (COVID-19) have an elevated risk of thrombotic events due to a high prevalence of cardiovascular risk factors, previous cardiovascular diseases and a pro-thrombotic status. |
| In patients with COVID-19 the thrombotic risk outweighs the bleeding risk. |
| Diagnostic and therapeutic approaches for thrombotic events in patients with COVID-19 should take into account the risk of contagion, the baseline risk profile and possible drug interactions. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.